FDA Inspection
Allermed Laboratories, Inc.Allermed Laboratories, Inc. – FDA Inspection, Sep 30, 2026
Record Details
This FDA Inspection record concerns Allermed Laboratories, Inc., with an inspection on September 30, 2026, issued by the Los Angeles District Office, covering biologics.
- Person
View Company Profile
ID · 9adf1a05-d729-474c-bf4c-fc7337074c91
Inspection Facts
- Inspection number
- 1338848
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.84(d)(2)Component written specification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Allermed Laboratories, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2024 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 12, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 14, 2017 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 13, 2015 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 12, 2013 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Allermed Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.